Jennerex Raises $5.1 Million for Oncology Pipeline
Vaccine company Jennerex has raised $5.1 million in a Series C round of financing.
Month: August 2009
OneMedPlace Interviews Jeffrey Davis, CEO of Access Pharmaceuticals
OneMedPlace recently sat down with Jeffrey Davis, CEO of Access Pharmaceuticals, to discuss the clinical success of MuGard and the latest news surrounding the product’s launch.
FDA Approves Harder-to-Abuse Painkiller Embeda
King Pharmaceuticals announced that the painkiller Embeda has been approved by the U.S. Food and Drug Administration for the management of moderate to severe chronic pain.
Anadys Shares Jump Following Hepatitis C Drug Trial
Shares in Anadys Pharmaceuticals rose 28 percent following the announcement of promising results in a clinical trial of its experimental hepatitis C drug ANA773.
Dendreon to Build $70 Million Plant Near Atlanta
The 160,000 square-foot facility could bring at least 300 jobs to Georgia.
New Software Brings Scientists Together
Imagine thousands of scientists across the globe collaborating to find a cure for cancer, or create a new malaria vaccine.
SyntheMed Receives Endorsement, New Patent
REPEL-CV, a bioresorbable anti-adhesion barrier developed by biomaterials company SyntheMed, has received an endorsement from Kids with Heart.
[Company Profile] Pressure BioSciences
Pressure BioSciences is developing a novel process called Pressure Cycling Technology (PCT) for sample preparation in the study of genomes and proteins.
Antidepressant Use Doubled In U.S. Over Past Decade
Antidepressant use in the U.S. nearly doubled between 1996 and 2005, according to a new report.
Purdue, Transcept Sign $145M Deal for Sleep Aid
Purdue Pharmaceutical Products and Transcept Pharmaceuticals have signed a $145 million agreement to commercialize the sleep aid Intermezzo in the U.S.